Track Sofinnova Partners's Investment Activity
Get real-time alerts when Sofinnova Partners makes new investments. Full investor profiles, co-investor networks, and deal history are available on Pro plans.
Sofinnova Partners
Genuine open application. Their site has a dedicated "Submit a project" form asking for your details, company description, a project synopsis and a business plan (uploads capped at 5MB each), plus a choice of which fund strategy and funding stage you are applying to. They ask for a value proposition, a synopsis covering target market and size, competitive position, management team, development stage and financing needs, and a non-confidential presentation.
Worth knowing. The form makes you pick one of seven strategies, and they are not all checks into existing companies. MD Start is described as an "in-house medtech accelerator focused on creating and launching early-stage medtech companies through hands-on company building", and Biovelocita is a biotech accelerator that partners with research organisations "to create and build" startups. Sofinnova Capital, the flagship, says it invests "as founding or lead investor". Picking the wrong strategy routes you to the wrong team, and note the submission asks explicitly for a NON-confidential presentation.
Built from 52 rounds we recorded since Dec 19, 2022.
See every fund writing checks into companies like yours, ranked, each with a route in.
Bionyra
Jun 22, 2026
Bionyra Pharma
Jun 22, 2026
Ingenix
Jun 3, 2026
P2 Science
May 26, 2026
CellCentric
May 6, 2026
45+ more investments
View all 52 deals by Sofinnova Partners
Fundz tracks 45,000 investors and their 13F holdings, alongside every round the companies they back raise.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.